Fisher Asset Management LLC Makes New $44.75 Million Investment in Cytokinetics, Incorporated (NASDAQ:CYTK)

Fisher Asset Management LLC purchased a new stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 535,954 shares of the biopharmaceutical company’s stock, valued at approximately $44,747,000. Fisher Asset Management LLC owned approximately 0.55% of Cytokinetics […]

Related Keywords

,Johnt Henderson ,Fady Ibraham Malik ,Td Asset Management Inc ,Morgan Stanley ,Legato Capital Management ,Securities Exchange Commission ,Cytokinetics Company Profile ,Cytokinetics Incorporated ,Vanguard Group Inc ,Fisher Asset Management ,Free Report ,Asset Management ,Management Inc ,Minvest Partners ,Get Free Report ,Director John ,Exchange Commission ,Ibraham Malik ,Cytokinetics Daily ,Cytokinetics ,Nasdaq Cytk ,Cytk ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,